Clinscience
EN
DE PL FR
MENU
X
⤺

Clinscience is a global CRO,
delivering meaningful value in the following areas

Clinical Development
Clinical Operations
Biostatistics and Data Management
Regulatory
Pharmacovigilance
Clinical Quality
Temporary Resourcing Solutions
Real-World Evidence
Market Access

Real world evidence

We have supported some of the largest real world evidence gathering programmes for postmarketing commitments but also for enhanced reimbursment.

LEARN MORE

We Build Trust In All Our Interactions

Our team have the experience of the nuances in the clinical development of small molecules, biological agents and advanced therapeutics. We have supported and continue to support pharmaceutical companies (big and small) and also biotechnology organisation

ABOUT US

Clinscience provide
a full-range of services to the following sectors

We provide clarity where there is ambiguity
and find opportunities when there is uncertainty

Therapeutic Area Expertise

Over the years we have supported organisations across many therapeutic areas, from pivotal global phase III oncology programmes through to very niche esoteric clinical packages of activity. Our passion for science, an unwavering commitment to improve the lives of patients and an unflagging energy to deliver on commitments has enabled us to gain broad expertise.

mainpage_pl_1_20190724212008.png
Oncology & Haematology Oncology & Haematology Orthopaedics & Wound Healing Orthopaedics & Wound Healing Central Nervous System (CNS) Central Nervous System (CNS) Women’s & Male Health Women’s & Male Health Immunology and Cancer Immunotherapy Immunology and Cancer Immunotherapy Respiratory Medicine Respiratory Medicine Cardiovascular Cardiovascular Dermatology Dermatology Metabolic & Endocrinology Metabolic & Endocrinology Biosimilars Biosimilars Rare & Orphan Disease Rare & Orphan Disease Gastroenterology Gastroenterology Ophthalmology Ophthalmology Infectious Diseases Infectious Diseases

Newsroom

A positive decision for BIOOPA study A positive decision for BIOOPA study At the beginning of October the Polish Competent Authority, Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products gave permission for conducting the BIOOPA clinical.
What are the new possibilities to help patients with melanoma? What are the new possibilities to help patients with melanoma? Melanoma is one of the most dangerous oncological diseases and although it accounts for only 4% of all dermatologic cancers, it is responsible for 80% of deaths from skin cancer. Study results have shown that only 14% of patients with metastatic melanoma survive for five years or more.
Clinscience joins forces with Experior to underpin the strong position on the European clinical trials market Clinscience joins forces with Experior to underpin the strong position on the European clinical trials market Following investments in Germany and Ukraine, the NEUCA Capital Group, through its subsidiary Clinscience, increases its CRO coverage by one of the largest clinical trials markets in Europe - Spain. By investing in Experior (100% shares), over a dozen million patients, develop competences in biostatistics, and expand this business area with new technological solutions.
SEE ALL NEWS
Request for information
LEARN MORE
Request for proposal
LEARN MORE
How can we help you?
CONTACT US
About Us
Meet the Team Our Mission Our Values Our Customers
Services
Clinical Development Clinical Operations Biostatistics and Data Management Regulatory Pharmacovigilance Clinical Quality Temporary Resourcing Solutions Real-World Evidence Market Access
Therapeutic Area Expertise
Oncology & Haematology Orthopaedics & Wound Healing Central Nervous System (CNS) Women’s & Male Health Immunology and Cancer Immunotherapy Respiratory Medicine Cardiovascular Dermatology Metabolic & Endocrinology Biosimilars Rare & Orphan Disease Gastroenterology Ophthalmology Infectious Diseases
Newsroom Announcements Blog Articles
Join Us Contact Request for proposal Request for information